But they don't always go back in the form of lower drug prices.
Editor's note · Context
DeGette discusses the issue of drug price rebates not always leading to lower prices.
Share
More from Diana DeGette
It is a little embarrassing for someone like me, who is trying to tell colleagues around the world that we need to have robust oversight, that the U.S. Congress is actually having an oversight hearing that is so vague that you can't…
These huge investments are necessary to take on the unprecedented challenges that our country faces, from climate change to healthcare costs to competition in global markets.
We have even reduced staffing at some of these agencies to a really dangerous level.
I was dismayed to hear that you did not receive the funding that you need to do your job. And I was pleased to hear that at least some of that funding is included in President Biden's budget this year.





